| ACTH(1-24)的应用研究进展 |
| |
| 引用本文： | 姚璐,周虹. ACTH(1-24)的应用研究进展[J]. 医学分子生物学杂志, 2005, 2(6): 444-447 |
| |
| 作者姓名： | 姚璐 周虹 |
| |
| 作者单位： | 军事医学科学院野战输血研究所,北京市,100850;北京军区总医院,北京市,100700;军事医学科学院野战输血研究所,北京市,100850 |
| |
| 基金项目： | 军事医学科学院学科培育项目，野战输血研究所战时输血保障工程项目(200405) |
| |
| 摘 要： | 失血性休克是临床上最常见的休克类型。促肾上腺皮质激素(adrenocorticotrphin,ACTH)的N端24肽[ACTH(1-24)]通过迷走神经抗炎通路的激活能快速、高效地发挥抗休克作用,并能降低休克的炎性连锁反应及显著减轻休克后器官的损伤和功能障碍,这将为新型药物的开发和急性失血性休克的治疗开辟新的领域。
|
| 关 键 词： | 失血性休克 ACTH(1-24) |
| 修稿时间： | 2005-04-12 |
Advances in the Research of ACTH (1-24) |
| |
| YAO Lu,ZHOU Hong. Advances in the Research of ACTH (1-24)[J]. Journal of Medical Molecular Biology, 2005, 2(6): 444-447 |
| |
| Authors: | YAO Lu ZHOU Hong |
| |
| Abstract: | Hemorrhagic shock is the most common type of shock in clinical practice.The adrenocorticotrophin fragment 1-24 [ ACTH (1-24) ] can effectively and quickly reverse hemorrhagic shock through the activation of a vagal anti-inflammatory pathway and suppression of inflammatory cascade thereby reducing the consequent damage and functional impairment of organs.It will open a new frontier for the development of novel medicines and research of hemorrhagic shock therapy.This article reviews the action and mechanism of ACTH (1-24) in reversing hemorrhagic shock. |
| |
| Keywords: | hemorrhagic shock ACTH (1-24) |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
